Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Mesko

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Oncology|November 29, 2018
Proton Therapy in Non-small Cell Lung CancerShane Mesko, Daniel Gomez
Current Opinion in Obstetrics & Gynecology|December 24, 2015
Moving from standardized to personalized boxes and pears in radiation planning for cervical cancerShane Mesko, Mitchell Kamrava
International Journal of Radiation Oncology, Biology, Physics|January 31, 2021
In Reply to SertShane Mesko, Daniel R Gomez
BJR Case Reports|October 27, 2018
Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal/vulvar melanoma: a case report and literature reviewShane Mesko, Gottfried E Konecny, Paul C Tumeh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological MalignanciesShane Mesko, Kiri Sandler, Joshua Cohen, et al.
Brachytherapy|December 25, 2014
A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapyShane Mesko, Sang-June Park, Amar U Kishan, et al.
Journal of Medical Imaging and Radiation Oncology|September 9, 2014
Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancerMelody P Chung, Dan Margolis, Shane Mesko, et al.
Prostate Cancer|November 14, 2013
Quantifying the ki-67 heterogeneity profile in prostate cancerShane Mesko, Patrick Kupelian, D Jeffrey Demanes, et al.
Anticancer Research|March 19, 2017
Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate CancerTimothy Ellis-Caleo, John V Hegde, Sukhjeet Batth, et al.
Brachytherapy|May 31, 2015
Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancerShane Mesko, Uma Swamy, Sang-June Park, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|November 29, 2018
Proton Therapy in Non-small Cell Lung CancerShane Mesko, Daniel Gomez
Current Opinion in Obstetrics & Gynecology|December 24, 2015
Moving from standardized to personalized boxes and pears in radiation planning for cervical cancerShane Mesko, Mitchell Kamrava
International Journal of Radiation Oncology, Biology, Physics|January 31, 2021
In Reply to SertShane Mesko, Daniel R Gomez
BJR Case Reports|October 27, 2018
Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal/vulvar melanoma: a case report and literature reviewShane Mesko, Gottfried E Konecny, Paul C Tumeh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological MalignanciesShane Mesko, Kiri Sandler, Joshua Cohen, et al.
Brachytherapy|December 25, 2014
A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapyShane Mesko, Sang-June Park, Amar U Kishan, et al.
Journal of Medical Imaging and Radiation Oncology|September 9, 2014
Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancerMelody P Chung, Dan Margolis, Shane Mesko, et al.
Prostate Cancer|November 14, 2013
Quantifying the ki-67 heterogeneity profile in prostate cancerShane Mesko, Patrick Kupelian, D Jeffrey Demanes, et al.
Anticancer Research|March 19, 2017
Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate CancerTimothy Ellis-Caleo, John V Hegde, Sukhjeet Batth, et al.
Brachytherapy|May 31, 2015
Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancerShane Mesko, Uma Swamy, Sang-June Park, et al.
Pageof 3